Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

Shares of Dr Reddy’s Laboratories surged over 4 percent in early trade on Thursday after the pharmaceutical company delivered a better-than-expected set of Q3 FY26 results, prompting brokerages to ...

Dr Reddy's India business saw robust double-digit growth, with revenue increasing 19% y-o-y to ₹1,603 crore. Hyderabad-based Dr Reddy’s Laboratories beat street estimates in the third quarter, ...

Hyderabad: Telangana Chief Minister A. Revanth Reddy has sought collaboration with the Harvard Kennedy School to strengthen education standards in the state during his ongoing executive leadership ...

Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...

Hyderabad: Chief Minister A. Revanth Reddy commenced his executive education programme at the Kennedy School of Government at Harvard University in Cambridge, Massachusetts, US. The inaugural academic ...

FREMONT, CA — From experiencing the driverless Waymo car in San Francisco, CA, to creating a new motto for Telangana to securing a series of investment deals and partnerships aimed at propelling ...

Good day, everyone, and welcome to the Quarter 3 FY '26 Earnings Call of Dr. Reddy's Laboratories Limited. We appreciate your continued interest in our company. I'm Aishwarya Sitharam, Head of ...

Hyderabad: Chief minister A Revanth Reddy on Sunday began an executive education programme at Harvard University's Kennedy School in Cambridge, Massachusetts, marking a rare academic engagement by a ...

Dr Reddy’s share price: At around 10:55 AM, the stock was trading at Rs 1,217.20, up Rs 60.00 or 5.18 per cent. The share opened at Rs 1,195, touched a high of Rs 1,224.50 and a low of Rs 1,187.70.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...